Peter Bhatt

Peter Bhatt is a pediatric oncologist at Children's Hospital of Philadelphia specializing in childhood acute lymphoblastic leukemia, with a focus on novel immunotherapies and genetic risk stratification. His research has focused on Philadelphia chromosome-like (Ph-like) ALL and targeted therapy approaches for this high-risk subgroup. He contributed to clinical trials of blinatumomab and CAR-T cell therapy in pediatric relapsed/refractory ALL. His work advances molecular subtype-driven therapy for children with leukemia.